Chetty U - Search Results

1

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.

Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM. Thompson AM, et al. Among authors: chetty u. Int J Cancer. 1992 Feb 20;50(4):528-32. doi: 10.1002/ijc.2910500405. Int J Cancer. 1992. PMID: 1537617

2

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM, Evans HJ. Prosser J, et al. Among authors: chetty u. Br J Cancer. 1992 Apr;65(4):527-8. doi: 10.1038/bjc.1992.109. Br J Cancer. 1992. PMID: 1562462 Free PMC article. No abstract available.

3

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

Thompson AM, Steel CM, Chetty U, Hawkins RA, Miller WR, Carter DC, Forrest AP, Evans HJ. Thompson AM, et al. Among authors: chetty u. Br J Cancer. 1990 Jan;61(1):74-8. doi: 10.1038/bjc.1990.17. Br J Cancer. 1990. PMID: 2137009 Free PMC article.

4

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

Mackay J, Elder PA, Porteous DJ, Steel CM, Hawkins RA, Going JJ, Chetty U. Mackay J, et al. Among authors: chetty u. Br J Cancer. 1988 Dec;58(6):710-4. doi: 10.1038/bjc.1988.295. Br J Cancer. 1988. PMID: 3066395 Free PMC article.

5

Transforming growth factor beta 1 is unlikely to mediate p53 abnormalities in breast cancer.

Thompson AM, Steel CM, Chetty U, Dixon JM, Carter DC. Thompson AM, et al. Among authors: chetty u. Br J Surg. 1995 Feb;82(2):210-1. doi: 10.1002/bjs.1800820223. Br J Surg. 1995. PMID: 7749692 No abstract available.

6

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.

Hubbard AL, Doris CP, Thompson AM, Chetty U, Anderson TJ. Hubbard AL, et al. Among authors: chetty u. Br J Cancer. 1994 Sep;70(3):434-9. doi: 10.1038/bjc.1994.323. Br J Cancer. 1994. PMID: 7915911 Free PMC article.

7

pS2 is an independent factor of good prognosis in primary breast cancer.

Thompson AM, Hawkins RA, Elton RA, Steel CM, Chetty U, Carter DC. Thompson AM, et al. Among authors: chetty u. Br J Cancer. 1993 Jul;68(1):93-6. doi: 10.1038/bjc.1993.292. Br J Cancer. 1993. PMID: 8318427 Free PMC article.

8

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

Thompson AM, Elton RA, Hawkins RA, Chetty U, Steel CM. Thompson AM, et al. Among authors: chetty u. Br J Cancer. 1998;77(3):492-6. doi: 10.1038/bjc.1998.78. Br J Cancer. 1998. PMID: 9472649 Free PMC article.

9

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.

Thompson AM, Crichton DN, Elton RA, Clay MF, Chetty U, Steel CM. Thompson AM, et al. Among authors: chetty u. Br J Cancer. 1998 Mar;77(5):797-800. doi: 10.1038/bjc.1998.129. Br J Cancer. 1998. PMID: 9514060 Free PMC article.

10

p53 mutations in breast cancer.

Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J. Coles C, et al. Among authors: chetty u. Cancer Res. 1992 Oct 1;52(19):5291-8. Cancer Res. 1992. PMID: 1394133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters